PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1864-6433
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time ; day:6 ; month:10 ; year:2018 ; pages:1-9
Annals of nuclear medicine ; (6.10.2018), 1-9
- Creator
-
Brumberg, Joachim
- Contributor
-
Tran-Gia, Johannes
Lapa, Constantin Frederik Victor
Isaias, Ioannis U.
Samnick, Samuel
SpringerLink (Online service)
- DOI
-
10.1007/s12149-018-1305-5
- URN
-
urn:nbn:de:101:1-2018111508172387283390
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brumberg, Joachim
- Tran-Gia, Johannes
- Lapa, Constantin Frederik Victor
- Isaias, Ioannis U.
- Samnick, Samuel
- SpringerLink (Online service)
Other Objects (12)
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Parkinson’s disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter
11C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
Parkinson
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Parkinson’s disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter
11C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
Parkinson
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Parkinson’s disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter
11C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease